Breaking News Instant updates and real-time market news.

SNAP

Snap

$14.00

-0.58 (-3.98%)

07:33
10/23/19
10/23
07:33
10/23/19
07:33

Snap upgraded to Hold from Underperform at Needham

Needham analyst Laura Martin upgraded Snap to Hold after its Q3 earnings beat, saying that based on its Q4 EBITDA guidance, she now expects the company to reach breakeven free cash flows in Q1 of 2020. The analyst notes that the company has "met its promise" to reduce costs and drive margin expansion, while its $1.1B convertible debt issuance in August has added to its balance sheet strength. Martin further cites Snap's improved revenue trajectory with a "growing number of 'always on' advertisers".

  • 21

    Nov

SNAP Snap
$14.00

-0.58 (-3.98%)

10/23/19
LEHM
10/23/19
NO CHANGE
Target $20
LEHM
Overweight
Barclays ups Snap target to $20 after upbeat conference call
Snap last night reported daily active users, revenue and EBITDA that were 3M, 3%, and $20M above consensus and sounded upbeat on its conference call, Barclays analyst Ross Sandler tells investors in a research note. He believes the consistency of Snap's results and communication are "likely to inspire confidence in the investment community over time." The analyst would add to positions on any weakness and boosted his price target for the shares to $20 from $19. Sandler keeps an Overweight rating on Snap.
10/23/19
STFL
10/23/19
NO CHANGE
Target $19
STFL
Buy
Stifel says 'don't be spooked,' Snap momentum remains intact
Snap reported upside to revenue, daily active users and adjusted EBITDA in Q3 and its outlook for Q4 met Street expectations, Stifel analyst John Egbert tells investors in a post-earnings research note titled "Don't Be Spooked; Audience Growth, Advertising Momentum, and Operating Leverage Remain Intact." The analyst sees a "clear path" to sustained profitability for Snap despite ongoing investments in sales, content, and longer-term platform and wearable computing initiatives. He reiterates a Buy rating on the shares with an unchanged price target of $19.
10/23/19
RSBL
10/23/19
NO CHANGE
Target $21
RSBL
Buy
Snap shares should be bought on post-earnings weakness, says Rosenblatt
Rosenblatt analyst Mark Zgutowicz reiterates his Buy rating and $21 price target on shares of Snap following the company's Q3 report, stating that he would be a buyer on any weakness in the shares today. Snap's outlook remains "stellar" in terms of both product and demand and he suspects the company's Q4 guidance will prove conservative, Zgutowicz tells investors. Beyond the upcoming holiday quarter, management remains focused on executing and he predicts "a long consistent trajectory ahead," the analyst added.
10/23/19
NEED
10/23/19
UPGRADE
NEED
Hold
Snap upgraded to Hold from Underperform at Needham

TODAY'S FREE FLY STORIES

DRRX

Durect

$1.94

0.04 (2.11%)

07:19
11/18/19
11/18
07:19
11/18/19
07:19
Initiation
Durect initiated  »

Durect assumed with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jan

ALGN

Align Technology

$264.02

3.59 (1.38%)

07:18
11/18/19
11/18
07:18
11/18/19
07:18
Recommendations
Align Technology analyst commentary  »

Align Technology price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GILT

Gilat Satellite

$7.34

-0.035 (-0.47%)

07:17
11/18/19
11/18
07:17
11/18/19
07:17
Hot Stocks
Gilat Satellite signs contract with SES to develop O3b mPOWER MEO system »

Gilat Satellite Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

BVXV

BiondVax

$5.85

0.07 (1.21%)

07:16
11/18/19
11/18
07:16
11/18/19
07:16
Hot Stocks
BiondVax says enrollment in Phase 3 trial of M-001 influenza vaccine complete »

BiondVax announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KRTX

Karuna Therapeutics

$17.26

-0.26 (-1.48%)

07:15
11/18/19
11/18
07:15
11/18/19
07:15
Conference/Events
Karuna Therapeutics to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

NBRV

Nabriva Therapeutics

$1.91

-0.085 (-4.27%)

07:13
11/18/19
11/18
07:13
11/18/19
07:13
Hot Stocks
Nabriva Therapeutics 'commends' CDC on 2019 antibiotic resistance threats report »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DRNA

Dicerna

$19.29

-0.86 (-4.27%)

07:12
11/18/19
11/18
07:12
11/18/19
07:12
Initiation
Dicerna initiated  »

Dicerna assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZG

Paramount Gold Nevada

$0.70

-0.01 (-1.41%)

07:11
11/18/19
11/18
07:11
11/18/19
07:11
Hot Stocks
Paramount Gold submits permit application for proposed Grassy Mountain project »

Paramount Gold Nevada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

SPWR

SunPower

$8.29

0.3 (3.75%)

07:10
11/18/19
11/18
07:10
11/18/19
07:10
Syndicate
SunPower files to sell 22M shares of common stock »

Goldman Sachs & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JAGX

Jaguar Health

$0.66

-0.0885 (-11.80%)

07:09
11/18/19
11/18
07:09
11/18/19
07:09
Recommendations
Jaguar Health analyst commentary  »

Jaguar Health price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRTX

Vertex

$209.97

4.96 (2.42%)

, MTEM

Molecular Templates

$7.23

0.22 (3.14%)

07:08
11/18/19
11/18
07:08
11/18/19
07:08
Hot Stocks
Vertex, Molecular Templates collaborate for targeted conditionining regimens »

Vertex Pharmaceuticals…

VRTX

Vertex

$209.97

4.96 (2.42%)

MTEM

Molecular Templates

$7.23

0.22 (3.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

ADUS

Addus HomeCare

$84.27

0.13 (0.15%)

07:08
11/18/19
11/18
07:08
11/18/19
07:08
Hot Stocks
Addus HomeCare provides update on operations in Illinois markets »

Addus HomeCare provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROK

Rockwell Automation

$200.22

1.32 (0.66%)

07:07
11/18/19
11/18
07:07
11/18/19
07:07
Conference/Events
Rockwell Automation to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 19

    Nov

  • 20

    Nov

SEEL

Seelos Therapeutics

$0.86

0.0702 (8.84%)

07:07
11/18/19
11/18
07:07
11/18/19
07:07
Recommendations
Seelos Therapeutics analyst commentary  »

Seelos Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORTX

Orchard Therapeutics

$10.39

-0.3 (-2.81%)

07:06
11/18/19
11/18
07:06
11/18/19
07:06
Hot Stocks
Orchard Therapeutics granted EMA accelerated assessment for OTL-200 »

Orchard Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

MYSZ

MySize

$0.36

-0.015 (-4.00%)

07:05
11/18/19
11/18
07:05
11/18/19
07:05
Hot Stocks
MySize announces one-for-fifteen reverse stock split »

My Size announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SDI

Standard Diversified

$10.89

-0.21 (-1.89%)

, TPB

Turning Point Brands

$26.59

0.15 (0.57%)

07:05
11/18/19
11/18
07:05
11/18/19
07:05
Hot Stocks
Standard Diversified intends to pursue merger with Turning Point Brands »

Standard Diversified…

SDI

Standard Diversified

$10.89

-0.21 (-1.89%)

TPB

Turning Point Brands

$26.59

0.15 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:05
11/18/19
11/18
07:05
11/18/19
07:05
General news
FX Update: The pound has rallied quite sharply »

FX Update: The pound has…

07:05
11/18/19
11/18
07:05
11/18/19
07:05
General news
European stock markets are mostly lower »

European stock markets…

TWTR

Twitter

$29.25

0.36 (1.25%)

07:05
11/18/19
11/18
07:05
11/18/19
07:05
Recommendations
Twitter analyst commentary  »

Twitter price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

GPOR

Gulfport Energy

$3.10

(0.00%)

07:04
11/18/19
11/18
07:04
11/18/19
07:04
Hot Stocks
Gulfport Energy says chairman David Houston will not seek re-election »

The Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPOR

Gulfport Energy

$3.10

(0.00%)

07:03
11/18/19
11/18
07:03
11/18/19
07:03
Hot Stocks
Gulfport Energy suspends share repurchase program, completes headcount reduction »

Gulfport Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LAD

Lithia Motors

$160.67

-0.19 (-0.12%)

07:03
11/18/19
11/18
07:03
11/18/19
07:03
Hot Stocks
Lithia Motors promotes Chris Holzshu to COO »

Lithia Motors announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALKS

Alkermes

$21.00

1.04 (5.21%)

07:03
11/18/19
11/18
07:03
11/18/19
07:03
Hot Stocks
Alkermes to acquire Rodin Therapeutics »

Alkermes and Rodin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WDAY

Workday

$165.93

1.17 (0.71%)

07:03
11/18/19
11/18
07:03
11/18/19
07:03
Downgrade
Workday rating change  »

Morgan Stanley cuts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.